Related Experiment Video
Updated: Mar 10, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial appendage closure: outcomes and challenges
H S Suradi1,2,3, Z M Hijazi4
1St Mary Medical Center, Community HealthCare Network, Hobart, IN, USA. Hussam_Suradi@rush.edu.
Insights
The left atrial appendage is a key source of stroke-causing clots in atrial fibrillation patients. Left atrial appendage closure offers an alternative to oral anticoagulation for preventing these cardioembolic events.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- The left atrial appendage (LAA) is a primary source of thrombus in patients with atrial fibrillation (AF).
- Oral anticoagulation (OAC) is the standard for stroke prevention in AF but has limitations and contraindications.
- Elderly patients with AF face a high stroke risk and often cannot tolerate OAC.
Purpose of the Study:
- To review the clinical outcomes of left atrial appendage closure (LAAC) in patients with atrial fibrillation.
- To discuss the challenges associated with LAAC procedures.
- To evaluate LAAC as an alternative stroke prevention strategy in AF.
Main Methods:
- Systematic review of clinical studies on LAAC in AF patients.
- Analysis of procedural success rates and complication profiles.
- Evaluation of long-term clinical outcomes, including stroke and bleeding events.
Main Results:
- LAAC effectively reduces the risk of cardioembolic events in AF patients.
- Various LAAC devices demonstrate favorable safety and efficacy profiles.
- Challenges include device selection, procedural complications, and long-term management.
Conclusions:
- Left atrial appendage closure is a viable and effective alternative to OAC for stroke prevention in select AF patients.
- Continued research is needed to optimize LAAC techniques and expand patient selection criteria.
- LAAC represents a significant advancement in managing stroke risk in atrial fibrillation.
Abstract:
Whereas the left atrial appendage plays a rather minor role under physiological circumstances, it gains an importance in patients with atrial fibrillation. Compelling evidence has revealed that the left atrial appendage is implicated as the source of thrombus in the vast majority of strokes in atrial fibrillation. Oral anticoagulation remains the standard of care for stroke prevention in atrial fibrillation; nevertheless, this treatment has several limitations and is often contraindicated, particularly in the elderly population in whom the risk of stroke is high. Therefore, occluding the left atrial appendage is a logical approach to prevent thrombus formation and subsequent cardioembolic events in these patients. We present a review of clinical outcomes of patients with atrial fibrillation undergoing left atrial appendage closure and the challenges faced in this field.
